CPA Urges President Biden to Address Decades of Failure by the FDA
WASHINGTON — The Coalition for a Prosperous America (CPA) urged President Joe Biden to address the decades of dereliction of duty by the Food and
CPA Letters to Leaders of House, Senate Health Care Committees Regarding FDA’s Failure on Essential Generic Medicines, Shortages
CPA sent the following letters to the Chairs and Ranking Members of the Senate Health, Education, Labor, and Pensions Committee and the House Energy and
CPA Letter to President Biden Regarding Essential Generic Medicines, Excessive Offshoring, and Failure of Safety and Efficacy
CPA sent the following letter to President Joe Biden requesting that his administration take action to address the failures of the Food and Drug Administration
FDA Funding Bill Heads to Final Committee, With One Major Stumbling Block
The Health subcommittee of the House Energy and Commerce Committee have moved the FDA user-fee reauthorization bill to final committee. Chairwoman Eshoo says it is on track for September approval.
CPA Launches Americans for Safe Drugs
Fighting Against Chinese & Indian Generic Pharmaceutical Manufacturers Exporting Unsafe Products to the U.S. WASHINGTON — The Coalition for a Prosperous America (CPA) today announced
House FDA Hearing: No Plan for Domestic Drug Manufacturing
A House committee hearing on the FDA focused on diversity in clinical trials, fast approval for cancer drugs, and no word on foreign vs domestic generic pharmaceutical labs.
Made in USA Pharma Supply Chain Amendment Passes Unanimously
Sen. Tina Smith’s bill to provide $500 million in grants for domestic pharmaceutical manufacturers passes with flying colors and will be part of PREVENT Pandemics Act.
House Hearing on FDA: Advanced Manufacturing May – or May Not – Lead to Domestic Manufacturing Boom
The House Committee on Energy and Commerce discussed FDA’s user fee budget and what can be done to reshore more of the pharmaceutical industry.
We Need to be Better at Industrial Policy
We Need to be Better at Industrial Policy By Amanda Mayoral, CPA Economist Industrial policy is critical to competing in a global economy and
Global Pharma Supply Chain Survey Shows Free Trade Not The Solution
Free trade loses out to a bigger government role in securing domestic supply chains of critical medication.
